Autopsy report · NCT07479381
Colorectal Lesion Evaluation and Appropriate Resolution (CLEAR) Study
Cause of deathFunding or business, also safety
“Study terminated per sponsor decision due to operational reasons. The termination was not a result of any participant safety concerns.”
Life of this trial
- Ran for about 0 months before it stopped.
- 14 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Harbinger Health
- Sponsor type
- Industry
- Conditions
- Colorectal Cancer (Diagnosis)
- Participants
- 14
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection
“Study was terminated by Sponsor; the decision was not due to any safety findings.” - A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome
“The study was terminated by Sponsor and the decision was not due to any safety or efficacy reasons.” - A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation
“The Sponsor terminated the study due to futility. The decision to stop the study was not based on safety concerns.” - Study of Ataluren (PTC124) in Hemophilia A and B
“Study was terminated early due to Sponsor decision and not reflective of adverse safety findings.” - PROPEL - A Prospective Observational Patient Registry to Evaluate ENPP1 and ABCC6 Deficiency
“The study was terminated by the sponsor prior to planned completion based on a review of the data across indications and overall program considerations. Study termination was not related to participant safety.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.